Calcium ions (Ca2+) play a substantial mediatory and regulatory role in nearly all cell activities. 3 types of ion channels are responsible for Ca2+ metabolism: receptoroperated calcium channels, voltage-gated calcium channels (VGCC) and store-operated calcium channels (Wray et al., 2001) ). VGCC is the principal mechanism of Ca2+ influx in spontaneously active myometrial tissue. The VGCC family L-type plays a vital role in the generation of phasic contractility of the uterus. Myometrial contractility depends on increase in intracellular Ca2+ resulting from the transmembrane influx of Ca2+ and the release of Ca2+ from endoplasmic reticulum (ER) (Noble et al., 2009 ). The main representative of store-operated channels is CRAC channel, which exhibits low conductance, strong inward rectification and remarkable Ca2+ selectivity (Sutovska et al., 2013; Parekh 2010) . The CRAC channel is composed of two main elements: Orai1 channel protein of the plasma membrane and stromal interaction molecule 1 (STIM1) protein of ER (Hoth and Penner, 1992; Potier and Trebak, 2008) . A decrease of Ca2+ concentration in the ER triggers changes in STIM1 conformation, the sensor of Ca2+ concentration in the ER. Opening the Orai1 channels causes an influx of Ca2+ into the cytoplasm of the cell. The rising concentration of Ca2+ in the cytoplasm induces closing of the channel by Ca2+-dependent inactivation (Derler et al., 2012) . Recently, the expression of CRAC channels in smooth muscle (SM), including the myometrium, has been confirmed (7, 8) . Therefore, this in vitro experimental study aimed to specify the role of CRAC channels in the contractility of human termpregnant and non-pregnant myometrium. Kazimierová I.
MATERIAL AND METHODS
The present in vitro study was focused on the differences in expression and activity of calcium release-activated calcium (CRAC) channels of human term-pregnant and non-pregnant myometrium. The expression of Orai1 protein, as a functional subunit of CRAC channel, was significantly higher than in non-pregnant myometrium. Lower Orai1 protein expression did not influence the amplitude of contractile response of term-pregnant myometrium, but higher Orai1 expression observed in non-pregnant myometrium was related to the different influence of CRAC blocker on contraction frequency.
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consent was obtained. Samples of myometrium were collected in cooperation with the Clinic of Gynaecology and Obstetrics. Human myometrium originated from woman without any underlying conditions and undergoing elective caesarean section at term (week of pregnancy 38.7 ± 0.7) and non-pregnant myometrium of women undergoing total hysterectomy (aged 47 ± 2.24) due to uterine myoma from macroscopic healthy tissue. Uterus SM reactivity was verified using the organ tissue bath methodology (Franova et al., 2009 ). Myometrium samples were incubated for one hour in Krebs-Henzeleit solution.
Oxytocin was applied directly into the chamber to induce SM contractions. Cumulative doses (1μM, 10μM, 100μM) of tested substance CRAC channel blocker 3-fluoropiridine-4carboxylic acid (FPCA) and salbutamol (100μM) were applied into the chamber after 5 minutes from oxytocin application. The amplitude and frequency of SM contraction was recorded.
The modulator of CRAC channels activity FPCA was purchased from TOCRIS (USA). Oxytocin and salbutamol were obtained from Sigma Aldrich SR. All substances were dissolved in aqua pro injection. Orai1 protein expression, a pore-forming subunit of the CRAC channel, was determined by immunohistochemistry. The reaction was visualized using the LSAB visualization kit and diaminobenzidine chromogen. The Orai1 expression was evaluated using a rating scale, where 1 stood for no degree of positivity, 2 mild or sporadic positivity and level 3 distinct positivity.
Fisher's exact test was selected to evaluate the IHC features and amplitude of contraction was evaluated using one-way ANOVA with Bonferroni post-hoc test.
RESuLTS
Uterus SM contractions, induced by oxytocin, were reduced after FPCA application. The amplitude of contractions was significantly reduced after the addition FPCA at 10 and 100 μM concentration in both groups (Tab. 1). The FPCA ability to reduce oxytocin-induced contraction were compared to clinically used drug salbutamol. FPCA effect in samples from non-pregnant women was comparable with salbutamol, but in samples from pregnant group, salbutamol was more effective than FPCA (Tab. 1). The frequency of uterine contractions from pregnant group reduced significantly after the application of CRAC channel blocker. The higher concentration of the tested substance led to an increase in the contraction frequency (Tab. 1). FPCA reduced the contraction frequency of myometrium from patients with myoma, which was almost comparable to the reference drug (Tab. 1). Higher expression of Orai1 protein was in samples from nonpregnant group than in samples of pregnant myometrium (Fig. 1) .
DIScuSSION
Recently, the expression of CRAC channels in smooth muscle, including the myometrium, has been confirmed in several studies. These studies confirmed the presence of CRAC channels not only in smooth muscle of myometrium but also in smooth muscle of respiratory tract and others (Sutovska et al. 2013; Potier and Trebak, 2008; Derler et al. 2012 ). The present study not only confirmed the expression of Orai1 protein, the main pore-forming subunit of CRAC channels in myometrium, but for the first time also distinguished distinct changes between Orai1 protein expression in non-pregnant myometrium and in term-pregnant myometrium. Functional part of this experimental study aimed to specify the role of CRAC channels in the contraction/relaxation of human term-pregnant and non-pregnant myometrium. Data presented in this paper provide strong evidence of CRAC channel's involvement in the contracting activity of myometrium. Moreover, lower expression of Orai1 protein did not influence the amplitude of the contractile response of term-pregnant myometrium on cumulative doses of CRAC blocker, but higher expression of Orai1 in non-pregnant myometrium was very probably related to different influence of this agent on frequency of contraction.
